Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.63−0.01 (-1.22%)
Close on Nov 13, 2026Market cap $3.53MP/E –Yield –
Imunon operating margin
Operating margin is operating income as a percentage of revenue.
Imunon's operating margin for the twelve months ending Dec 31, 2022 was -4984.3%. For fiscal 2022 it was -4984.3%, against -4201.4% the year before. The highest annual figure on record is -3693.7% in fiscal 2017.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -4984.3% | −782.9 |
| FY2021 | Dec 31, 2021 | -4201.4% | −504.2 |
| FY2020 | Dec 31, 2020 | -3697.3% | +415.8 |
| FY2019 | Dec 31, 2019 | -4113.1% | +99.9 |
| FY2018 | Dec 31, 2018 | -4213.0% | −519.3 |
| FY2017 | Dec 31, 2017 | -3693.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -5541.4% | −1148.7 |
| Q3 FY2022 | Sep 30, 2022 | -4939.7% | −890.4 |
| Q2 FY2022 | Jun 30, 2022 | -4782.6% | −725.5 |
| Q1 FY2022 | Mar 31, 2022 | -4673.6% | −366.9 |
| Q4 FY2021 | Dec 31, 2021 | -4392.7% | −557.6 |
| Q3 FY2021 | Sep 30, 2021 | -4049.3% | −721.6 |
| Q2 FY2021 | Jun 30, 2021 | -4057.1% | −243.5 |
| Q1 FY2021 | Mar 31, 2021 | -4306.7% | −493.9 |
| Q4 FY2020 | Dec 31, 2020 | -3835.1% | −37.0 |
| Q3 FY2020 | Sep 30, 2020 | -3327.7% | +982.3 |
| Q2 FY2020 | Jun 30, 2020 | -3813.6% | +642.2 |
| Q1 FY2020 | Mar 31, 2020 | -3812.8% | +75.7 |
| Q4 FY2019 | Dec 31, 2019 | -3798.1% | +2.2 |
| Q3 FY2019 | Sep 30, 2019 | -4310.0% | −1092.2 |
| Q2 FY2019 | Jun 30, 2019 | -4455.8% | +1953.3 |
| Q1 FY2019 | Mar 31, 2019 | -3888.4% | −463.5 |
| Q4 FY2018 | Dec 31, 2018 | -3800.3% | −55.3 |
| Q3 FY2018 | Sep 30, 2018 | -3217.8% | +300.7 |
| Q2 FY2018 | Jun 30, 2018 | -6409.1% | −2890.6 |
| Q1 FY2018 | Mar 31, 2018 | -3424.9% | +429.8 |
| Q4 FY2017 | Dec 31, 2017 | -3745.0% | – |
| Q3 FY2017 | Sep 30, 2017 | -3518.5% | – |
| Q2 FY2017 | Jun 30, 2017 | -3518.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -3854.7% | – |
See a number that looks wrong?